The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBCN.L Regulatory News (BCN)

  • There is currently no data for BCN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

31 Aug 2021 08:38

RNS Number : 1991K
Citigroup Global Markets Limited
31 August 2021
 

 

 

 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Citigroup Global Markets Limited

(b) Name of offeror/offeree in relation to whoserelevant securities this form relates:Use a separate form for each offeror/offeree

Bacanora Lithium plc

(c) Name of the party to the offer with which exemptprincipal trader is connected:

Bacanora Lithium plc

(d) Date dealing undertaken:

27 August 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received(GBP)

Lowest price per unit paid/received(GBP)

10p ordinary

Purchase

26,127

0.6650

0.6650

10p ordinary

Sale

26,127

0.6650

0.6650

 

(b) Cash-settled derivative transactions

 

 

Class of relevant security

Product description e.g. CFD

Nature of dealinge.g. opening/closing along/short position,increasing/reducing along/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing,selling,varying etc.

Number of securities towhich option relates

Exercise price per unit

Typee.g. American,European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercise

 

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number ofsecurities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

 

Class of relevant security

Nature of dealinge.g. subscription, conversion

Details

Price per unit(if applicable)

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,formal or informal, relating to relevant securities which may be an inducement to dealor refrain from dealing entered into by the exempt principal trader making thedisclosure and any party to the offer or any person acting in concert witha party to the offer:

 

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, betweenthe exempt principal trader making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

If there are no such agreements, arrangements or understandings, state "none"

None

 

Date of disclosure:

31 August 2021

Contact name:

Craig Watson

Telephone number:

+44 (28) 9040-9605

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory InformationService and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERFZGFRNMNGMZG
Date   Source Headline
1st Sep 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
1st Sep 202111:41 amRNSForm 8.3 - Bacanora Lithium plc
1st Sep 20219:38 amRNSForm 8.5 (EPT/RI)
31st Aug 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
31st Aug 20219:53 amRNSForm 8.5 (EPT/RI)
31st Aug 20218:38 amRNSForm 8.5 (EPT/RI)
27th Aug 20213:37 pmRNSForm 8.3 - Bacanora Lithium plc
27th Aug 202112:55 pmPRNForm 8.3 - Bacanora Lithium plc
27th Aug 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
27th Aug 20219:33 amRNSForm 8.5 (EPT/RI)
26th Aug 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
26th Aug 20219:27 amRNSForm 8.5 (EPT/RI)
25th Aug 20214:40 pmRNSSecond Price Monitoring Extn
25th Aug 20214:35 pmRNSPrice Monitoring Extension
25th Aug 20213:02 pmRNSOffer for Bacanora Lithium PLC
25th Aug 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
25th Aug 202110:09 amRNSForm 8.5 (EPT/RI)
24th Aug 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
24th Aug 20219:43 amRNSForm 8.5 (EPT/RI)
24th Aug 20217:00 amRNSUpdate on Orr-Ewing Royalty Dispute
23rd Aug 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
20th Aug 202112:11 pmRNSForm 8.3 - Bacanora Lithium plc
20th Aug 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
19th Aug 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
18th Aug 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
17th Aug 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
17th Aug 20218:54 amRNSForm 8.5 (EPT/RI)
16th Aug 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
16th Aug 20217:14 amRNSForm 8.5 (EPT/RI)
13th Aug 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
13th Aug 20219:50 amRNSForm 8.5 (EPT/RI)
13th Aug 20217:31 amRNSForm 8.5 (EPT/RI)
12th Aug 202112:00 pmRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
12th Aug 20219:53 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
12th Aug 20219:10 amRNSForm 8.5 (EPT/RI)
12th Aug 20218:42 amRNSForm 8.5 (EPT/RI)
9th Aug 202111:08 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
6th Aug 202110:06 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
6th Aug 20219:54 amRNSForm 8.5 (EPT/RI)
5th Aug 20219:21 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
4th Aug 202110:25 amRNSForm 8.5 (EPT/RI)
4th Aug 20219:35 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
3rd Aug 202112:51 pmRNSForm 8.3 - Bacanora Lithium plc
3rd Aug 202110:37 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
3rd Aug 202110:16 amRNSForm 8.5 (EPT/RI)
2nd Aug 202111:09 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
30th Jul 202112:10 pmRNSForm 8.3 - BACANORA LITHIUM PLC
30th Jul 202111:17 amRNSForm 8.5 (EPT/RI) - Bacanora Lithium Plc
30th Jul 20219:19 amRNSForm 8.5 (EPT/RI)
29th Jul 202111:50 amRNSForm 8.3 - BACANORA LITHIUM PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.